معرفی
Stefano Romeo is a Professor in Molecular and Clinical Medicine at the Sahlgrenska Academy, University of Gothenburg, and a Senior Consultant in Endocrinology at Sahlgrenska University Hospital. He holds a Medical Degree from Campus Biomedico University (2001, Italy) and completed his residency in Endocrinology at Sapienza University of Rome (2006). He has held postdoctoral positions at the University of Texas Southwestern Medical Center (2006–2009) and the University of Cambridge (2009–2011).
- Affiliations: Wallenberglab, Sahlgrenska University Hospital, and University Magna Graecia (Italy).
Research Focus: Genetic determinants of metabolic disorders, including fatty liver disease (FLD) and cardiovascular disease (CVD). Key contributions include identifying PNPLA3, MBOAT7, and PSD3 as critical genes in FLD, developing 3D liver models, and pioneering precision medicine approaches. In CVD, he developed a machine-learning algorithm for familial hypercholesterolemia (FH) diagnosis and identified LPL mutations linked to severe hypertriglyceridemia.
Clinical Leadership: Director of the Lipid Clinic at Sahlgrenska University Hospital since 2014, focusing on genetic screening for FH and hyperlipidemia management across the Västra Götaland region.
Awards & Recognition:
- International Laureate Chair Prize (2023)
- Leif Groop Award (2021)
- Knut and Alice Wallenberg Academy Fellowship (2017)
Labs & Teams: Leads a multidisciplinary team including researchers (Rosellina Mancina, Ester Ciociola), postdocs (Kavitha Sasidharan), and students (Tanmoy Dutta). Collaborates with the Lipid Clinic team, including clinicians and residents.
